DEXLANSOPRAZOLE DR (dexlansoprazole)
PEPTIC ULCER AGENTS · EROSIVE ESOPHAGITIS ·+3
REMEDYREPACK, I
Drug class
Peptic Ulcer Agents
Peptic ulcer agents, broadly cataloged in medical taxonomies as anti-ulcer agents, encompass a diverse therapeutic class of medications formulated to prevent and treat erosive acid-peptic disorders. Read more about Peptic Ulcer Agents
513 drugs in this class 187 manufacturers
Drugs in Peptic Ulcer Agents
ESOMEPRAZOLE MAGNESIUM
PEPTIC ULCER AGENTS · ZOLLINGER-ELLISON SYNDROME ·+9
REMEDYREPACK, I
LANSOPRAZOLE
PEPTIC ULCER AGENTS · ZOLLINGER-ELLISON SYNDROME ·+13
MEDCORE, LLC
FAMOTIDINE
PEPTIC ULCER AGENTS · MULTIPLE ENDOCRINE NEOPLASIA ·+13
GLENMARK THERAP
IBUPROFEN-FAMOTIDINE (ibuprofen/famotidine)
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · RHEUMATOID ARTHRITIS IN PATIENT AT HIGH GASTRIC ULCER RISK ·+1
VIONA PHARMACEU
IBUPROFEN-FAMOTIDINE (ibuprofen/famotidine)
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · RHEUMATOID ARTHRITIS IN PATIENT AT HIGH GASTRIC ULCER RISK ·+1
ENOVACHEM MANUF
ESOMEPRAZOLE MAGNESIUM
PEPTIC ULCER AGENTS · ZOLLINGER-ELLISON SYNDROME ·+9
AVPAK
SUCRALFATE
PEPTIC ULCER AGENTS · DUODENAL ULCER ·+1
SAFECOR HEALTH
NAPROXEN-ESOMEPRAZOLE MAG (naproxen/esomeprazole magnesium)
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · RHEUMATOID ARTHRITIS IN PATIENT AT HIGH GASTRIC ULCER RISK ·+3
ENOVACHEM MANUF
Filter & compare in the drug finder →
Opens the drug finder with Peptic Ulcer Agents preselected. Add indication or manufacturer filters there.
Peptic ulcer agents, broadly cataloged in medical taxonomies as anti-ulcer agents, encompass a diverse therapeutic class of medications formulated to prevent and treat erosive acid-peptic disorders.
These agents primarily function either by reducing gastric acid production and acidity—via proton pump inhibition, histamine H2-receptor blockade, or chemical neutralization—or by enhancing mucosal cytoprotection and forming physical barriers over damaged tissue.
Clinically, they are indicated for the management of gastric and duodenal ulcers, gastroesophageal reflux disease, pathological hypersecretory states like Zollinger-Ellison syndrome, and the prevention of mucosal damage caused by nonsteroidal anti-inflammatory drugs.
Additionally, antisecretory members of this class serve as critical components in antimicrobial combination regimens to eradicate *Helicobacter pylori* infections.
-
nih.gov
Peptic ulcer agents, broadly cataloged in medical taxonomies as anti-ulcer agents, encompass a diverse therapeutic class of medications formulated to prevent and treat erosive acid-peptic disorders
-
nih.gov
Peptic ulcer agents, broadly cataloged in medical taxonomies as anti-ulcer agents, encompass a diverse therapeutic class of medications formulated to prevent and treat erosive acid-peptic disorders Clinically, they are indicated for the management of gastric and duodenal ulcers, gastroesophageal reflux disease, pathological hypersecretory states like Zollinger-Ellison syndrome, and the prevention of mucosal damage caused by nonsteroidal anti-inflammatory drugs Additionally, antisecretory members...
-
nih.gov
These agents primarily function either by reducing gastric acid production and acidity—via proton pump inhibition, histamine H2-receptor blockade, or chemical neutralization—or by enhancing mucosal cytoprotection and forming physical barriers over damaged tissue Clinically, they are indicated for the management of gastric and duodenal ulcers, gastroesophageal reflux disease, pathological hypersecretory states like Zollinger-Ellison syndrome, and the prevention of mucosal damage caused by nonster...
-
nih.gov
These agents primarily function either by reducing gastric acid production and acidity—via proton pump inhibition, histamine H2-receptor blockade, or chemical neutralization—or by enhancing mucosal cytoprotection and forming physical barriers over damaged tissue
-
nih.gov
Clinically, they are indicated for the management of gastric and duodenal ulcers, gastroesophageal reflux disease, pathological hypersecretory states like Zollinger-Ellison syndrome, and the prevention of mucosal damage caused by nonsteroidal anti-inflammatory drugs
-
nih.gov
Additionally, antisecretory members of this class serve as critical components in antimicrobial combination regimens to eradicate *Helicobacter pylori* infections
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.